Louis Archambault
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Louis Archambault has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Luc Beaulieu
Physique, génie physique et optique, Universite Laval, 2375 rue de la Terrasse, 1401 18e rue, Quebec, G1J 1Z4, CANADA
10 shared publications François Therriault-Proulx
Medscint
8 shared publicationsSimon Lambert-Girard
Medscint
7 shared publicationsNicolas Varfalvy
Département de radio-oncologie, Centre Hospitalier Universitaire de Québec, Québec, Québec, Canada
4 shared publications- Boby Lessard
Physique, génie physique et optique, Universite Laval Faculte des Sciences et de Genie, 2375 rue de la Terrasse, Québec City, Quebec, G1V 0A6, CANADA
3 shared publications Danahé LeBlanc
Medscint Inc. Québec QC Canada
3 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 3327 (1)
Monte-Carlo simulations of Cherenkov Fluence for FLASH radiotherapy dosimetry
FLASH radiotherapy uses ultra-high dose rate (UHDR) beams to reduce normal tissue toxicity while maintaining tumor control. However, accurate dosimetry for UHDR beams is challenging due to saturation effects and temporal limitations of conventional detectors. Optical methods using Cherenkov radiation represent a promising alternative with a non-invasive method, but the Cherenkov signal is anisotropic and depends on particle direction and optical transport. Monte Carlo simulations using TOPAS were performed to investigate Cherenkov photon fluence produced by clinical electron beams in water, quantifying photon production, absorbed dose, and the optical signal at the detection plane. The results allow comparison between absorbed dose, Cherenkov photon production, and the detected optical signal, providing insight into the relationship between Cherenkov emission and deposited dose for potential applications in FLASH dosimetry.
- 1 September 2026
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 3327 (1)
Open AccessMonte-Carlo simulations of Cherenkov Fluence for FLASH radiotherapy dosimetry
FLASH radiotherapy uses ultra-high dose rate (UHDR) beams to reduce normal tissue toxicity while maintaining tumor control. However, accurate dosimetry for UHDR beams is challenging due to saturation effects and temporal limitations of conventional detectors. Optical methods using Cherenkov radiation represent a promising alternative with a non-invasive method, but the Cherenkov signal is anisotropic and depends on particle direction and optical transport. Monte Carlo simulations using TOPAS were performed to investigate Cherenkov photon fluence produced by clinical electron beams in water, quantifying photon production, absorbed dose, and the optical signal at the detection plane. The results allow comparison between absorbed dose, Cherenkov photon production, and the detected optical signal, providing insight into the relationship between Cherenkov emission and deposited dose for potential applications in FLASH dosimetry.
- Open Access
- 1 September 2026
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 3327 (1)
Uncertainty-Aware Deep Learning Reconstruction for 3D Scintillation Dosimetry
Scintillation dosimetry enables three-dimensional (3D) dose measurements for quality assurance in radiation therapy through the tomographic reconstruction of scintillation light. With their very fast reconstruction time and high representational capacity, deep learning methods are a promising approach for this reconstruction problem in a limited-view setting where real-time capacity is crucial. However, these reconstruction techniques are hard to interpret and generally give no confidence level on their predictions. In this work, we propose a Bayesian neural network framework for uncertainty estimation in the reconstruction of 3D dose distribution. Results show that predicted uncertainty correlates with reconstruction error, with Pearson correlation coefficients of 0.61 ± 0.06 for the gamma index and 0.94 ± 0.01 for absolute error. It was also found that no statistically significant difference is present between the Bayesian model and its deterministic counterpart, yielding promising results for safer quality assurance.
- 1 September 2026
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 3327 (1)
Open AccessUncertainty-Aware Deep Learning Reconstruction for 3D Scintillation Dosimetry
Scintillation dosimetry enables three-dimensional (3D) dose measurements for quality assurance in radiation therapy through the tomographic reconstruction of scintillation light. With their very fast reconstruction time and high representational capacity, deep learning methods are a promising approach for this reconstruction problem in a limited-view setting where real-time capacity is crucial. However, these reconstruction techniques are hard to interpret and generally give no confidence level on their predictions. In this work, we propose a Bayesian neural network framework for uncertainty estimation in the reconstruction of 3D dose distribution. Results show that predicted uncertainty correlates with reconstruction error, with Pearson correlation coefficients of 0.61 ± 0.06 for the gamma index and 0.94 ± 0.01 for absolute error. It was also found that no statistically significant difference is present between the Bayesian model and its deterministic counterpart, yielding promising results for safer quality assurance.
- Open Access
- 14 June 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (11) , 115005
Evaluation of the hyperspectral multicomponent calibration for plastic scintillation dosimetry
Objective. Accurate and precise dose measurements are critical for the validation of radiotherapy treatments. Plastic scintillation dosimeters (PSDs), when carefully calibrated, offer a solution. This study provides a systematic investigation of different calibration methods for PSDs based on hyperspectral identification of scintillation. Furthermore, performance of these calibration methods is evaluated for a conventional linac and an MR-linac. Approach. For this study, seven calibration types were applied, each considering a different number of physical and optical components, including different combinations. The inclusion of a component was analysed by evaluating the residual, which provided information about the amount of unlabelled signal. The residuals and the measured doses were evaluated for reproducibility, output factors and angular dependence. The error of the dose measurement offers an indication of how effectively the scintillation component is identified. Main results. The addition of calibration components, such as Cherenkov (proximal and distal), fluorescence, and drift correction, resulted in a progressive reduction in the residual. Consequently, a smaller proportion of the signal remained unlabelled. The absolute dose differences across the measurements also decreased with the addition of components. The inclusion of the Cherenkov component yielded the most substantial improvement in accuracy. For example, the dose discrepancy decreased from more than 70% to less than 1% for large field sizes on the MR-linac. Significance. These findings demonstrate that the hyperspectral calibration significantly improves PSD accuracy and precision, particularly with the inclusion of the Cherenkov component. This improvement is observed consistently across different setups and on both the conventional linac and the MR-linac.
- 14 June 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (11) , 115005
Open AccessEvaluation of the hyperspectral multicomponent calibration for plastic scintillation dosimetry
Objective. Accurate and precise dose measurements are critical for the validation of radiotherapy treatments. Plastic scintillation dosimeters (PSDs), when carefully calibrated, offer a solution. This study provides a systematic investigation of different calibration methods for PSDs based on hyperspectral identification of scintillation. Furthermore, performance of these calibration methods is evaluated for a conventional linac and an MR-linac. Approach. For this study, seven calibration types were applied, each considering a different number of physical and optical components, including different combinations. The inclusion of a component was analysed by evaluating the residual, which provided information about the amount of unlabelled signal. The residuals and the measured doses were evaluated for reproducibility, output factors and angular dependence. The error of the dose measurement offers an indication of how effectively the scintillation component is identified. Main results. The addition of calibration components, such as Cherenkov (proximal and distal), fluorescence, and drift correction, resulted in a progressive reduction in the residual. Consequently, a smaller proportion of the signal remained unlabelled. The absolute dose differences across the measurements also decreased with the addition of components. The inclusion of the Cherenkov component yielded the most substantial improvement in accuracy. For example, the dose discrepancy decreased from more than 70% to less than 1% for large field sizes on the MR-linac. Significance. These findings demonstrate that the hyperspectral calibration significantly improves PSD accuracy and precision, particularly with the inclusion of the Cherenkov component. This improvement is observed consistently across different setups and on both the conventional linac and the MR-linac.
- Open Access
Biomarkers for Precision Prognosis in Prostate Cancer: Imaging, Molecular, and Integrated Approaches
Prostate cancer (PCa) is predominantly an acinar adenocarcinoma arising from the prostatic glandular epithelium, with tumor grade assessed using the International Society of Urological Pathology (ISUP) Grade Group classification, reflecting the degree of glandular differentiation and underlying molecular heterogeneity. PCa exhibits wide clinical behavior heterogeneity, ranging from indolent disease to aggressive forms with poor outcomes. Accurate prognostic assessment is, therefore, essential for guiding treatment selection and monitoring disease progression. This review examines recent advances in imaging and non-imaging biomarkers that contribute to improved risk stratification, treatment planning, and disease monitoring. Particular attention is given to multiparametric magnetic resonance imaging (mpMRI), whole-body magnetic resonance imaging (WB-MRI), positron emission tomography/computed tomography (PET/CT), positron emission tomography/magnetic resonance imaging (PET/MRI), computed tomography (CT), and transrectal ultrasound (TRUS), evaluated for their capacity not only to detect disease but also to predict recurrence, progression, and survival outcomes. In parallel, the prognostic role of non-imaging biomarkers is discussed, including the prostate-specific antigen (PSA), histopathological grading, biochemical and inflammatory biomarkers, as well as genomic classifiers and circulating tumor DNA (ctDNA). Emerging approaches such as radiomics, liquid-biopsy-derived molecular profiles, and artificial intelligence (AI)-based multimodal integration are highlighted for their potential to enhance individualized decision making. This review underscores the importance of combining imaging and molecular information to refine prognostic models and accelerate the translation of precision medicine in PCa.
Open AccessBiomarkers for Precision Prognosis in Prostate Cancer: Imaging, Molecular, and Integrated Approaches
Prostate cancer (PCa) is predominantly an acinar adenocarcinoma arising from the prostatic glandular epithelium, with tumor grade assessed using the International Society of Urological Pathology (ISUP) Grade Group classification, reflecting the degree of glandular differentiation and underlying molecular heterogeneity. PCa exhibits wide clinical behavior heterogeneity, ranging from indolent disease to aggressive forms with poor outcomes. Accurate prognostic assessment is, therefore, essential for guiding treatment selection and monitoring disease progression. This review examines recent advances in imaging and non-imaging biomarkers that contribute to improved risk stratification, treatment planning, and disease monitoring. Particular attention is given to multiparametric magnetic resonance imaging (mpMRI), whole-body magnetic resonance imaging (WB-MRI), positron emission tomography/computed tomography (PET/CT), positron emission tomography/magnetic resonance imaging (PET/MRI), computed tomography (CT), and transrectal ultrasound (TRUS), evaluated for their capacity not only to detect disease but also to predict recurrence, progression, and survival outcomes. In parallel, the prognostic role of non-imaging biomarkers is discussed, including the prostate-specific antigen (PSA), histopathological grading, biochemical and inflammatory biomarkers, as well as genomic classifiers and circulating tumor DNA (ctDNA). Emerging approaches such as radiomics, liquid-biopsy-derived molecular profiles, and artificial intelligence (AI)-based multimodal integration are highlighted for their potential to enhance individualized decision making. This review underscores the importance of combining imaging and molecular information to refine prognostic models and accelerate the translation of precision medicine in PCa.
- 13 May 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 221, 111598
Pelvic nodes ultra-hypo fractionated versus conventionally fractionated IMRT with HDR brachytherapy in prostate cancer: interim analysis of a collaborative multi-institutional non-inferiority phase 3 trial (PCS-XI, NCT05820633)
- 13 May 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 221, 111598
Pelvic nodes ultra-hypo fractionated versus conventionally fractionated IMRT with HDR brachytherapy in prostate cancer: interim analysis of a collaborative multi-institutional non-inferiority phase 3 trial (PCS-XI, NCT05820633)
- Open Access
- 3 April 2026
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 27 (4) , e70563
Assessing inter‐observer variability in prostate and GTV segmentation on mpMRI: A comparison between radiation oncologists and AI‐based method
Background Accurate delineation of the prostate and intraprostatic gross tumor volume (GTV) on multiparametric MRI (mpMRI) is critical for radiation therapy planning, particularly for focal dose escalation strategies. However, interpretation of mpMRI can be challenging and prone to inter-observer variability, especially among radiation oncologists (ROs) who may have limited training in prostate MRI interpretation. In addition, because many patients do not undergo diagnostic mpMRI before treatment, radiologist input is often absent during treatment planning, which can compromise accurate GTV delineation. Purpose To evaluate approaches for improving focal prostate GTV delineation on mpMRI for radiotherapy planning, by assessing the impact of radiology reports on ROs contours, and comparing the performance of an automated segmentation tool (AIRC) with radiologists' contours as a potential replacement when radiologist input is unavailable. Methods Twenty patients underwent mpMRI at our institution. Delineation of the prostate gland and GTV was performed by ROs in two phases. In the first phase, ROs segmented both structures with access only to biopsy results, indicating positive core locations. In the second phase, they repeated the segmentation with access to the radiology report. AIRC segmented both structures as well, using the same images as made available to the ROs. Lesion detection performance was evaluated using sensitivity and positive predictive value (PPV). Segmentations were compared to consensus contours from two radiologists using the STAPLE algorithm. Similarity metrics computed included Dice similarity coefficient (DSC), Hausdorff distance (HD), distance from center, and relative volume difference. Results Prostate gland segmentation showed minimal inter-observer variability and high agreement with the reference, with a mean DSC of for ROs and for AIRC. In contrast, GTV segmentation demonstrated substantial variability and a high number of false positives and missed lesions when ROs lacked access to the radiology report. PPV significantly improved during the second attempt with access to the radiology report ( ), and similarity metrics improved significantly across all measures ( ). Sensitivity also increased in the second attempt, although not significantly ( ). AIRC performance was comparable to the ROs' first attempt. Conclusions High inter-observer variability in GTV segmentation was observed when ROs lacked access to the radiology report, underscoring the difficulty of mpMRI interpretation. Providing radiology reports and establishing standardized guidelines for mpMRI interpretation may improve segmentation accuracy and consistency. An Automated segmentation tool could facilitate the first step in the planning workflow by assisting ROs in target definition.- 3 April 2026
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 27 (4) , e70563
Open AccessAssessing inter‐observer variability in prostate and GTV segmentation on mpMRI: A comparison between radiation oncologists and AI‐based method
Background Accurate delineation of the prostate and intraprostatic gross tumor volume (GTV) on multiparametric MRI (mpMRI) is critical for radiation therapy planning, particularly for focal dose escalation strategies. However, interpretation of mpMRI can be challenging and prone to inter-observer variability, especially among radiation oncologists (ROs) who may have limited training in prostate MRI interpretation. In addition, because many patients do not undergo diagnostic mpMRI before treatment, radiologist input is often absent during treatment planning, which can compromise accurate GTV delineation. Purpose To evaluate approaches for improving focal prostate GTV delineation on mpMRI for radiotherapy planning, by assessing the impact of radiology reports on ROs contours, and comparing the performance of an automated segmentation tool (AIRC) with radiologists' contours as a potential replacement when radiologist input is unavailable. Methods Twenty patients underwent mpMRI at our institution. Delineation of the prostate gland and GTV was performed by ROs in two phases. In the first phase, ROs segmented both structures with access only to biopsy results, indicating positive core locations. In the second phase, they repeated the segmentation with access to the radiology report. AIRC segmented both structures as well, using the same images as made available to the ROs. Lesion detection performance was evaluated using sensitivity and positive predictive value (PPV). Segmentations were compared to consensus contours from two radiologists using the STAPLE algorithm. Similarity metrics computed included Dice similarity coefficient (DSC), Hausdorff distance (HD), distance from center, and relative volume difference. Results Prostate gland segmentation showed minimal inter-observer variability and high agreement with the reference, with a mean DSC of for ROs and for AIRC. In contrast, GTV segmentation demonstrated substantial variability and a high number of false positives and missed lesions when ROs lacked access to the radiology report. PPV significantly improved during the second attempt with access to the radiology report ( ), and similarity metrics improved significantly across all measures ( ). Sensitivity also increased in the second attempt, although not significantly ( ). AIRC performance was comparable to the ROs' first attempt. Conclusions High inter-observer variability in GTV segmentation was observed when ROs lacked access to the radiology report, underscoring the difficulty of mpMRI interpretation. Providing radiology reports and establishing standardized guidelines for mpMRI interpretation may improve segmentation accuracy and consistency. An Automated segmentation tool could facilitate the first step in the planning workflow by assisting ROs in target definition. - 14 January 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (3)
Polarized Cherenkov light imaging dosimetry: the impact of source to detector distance
Objective: With every treatment vault being different, the impact of geometrical parameters such as the signal source-to-camera distance on dose proportionality must be evaluated. The aim of this study is to characterize the Cherenkov signal and polarization state as a function of the source-to-camera distance. Our hypothesis is that with increasing distance, the need for angular correction distributions decreases, resulting in acquisition of a polarized Cherenkov signal directly proportional to dose. Approach: A water tank and a polyvinyltoluene-based plastic scintillator volume were irradiated by a 6 MV beam to respectively produce Cherenkov emissions as well as a control signal. Monte Carlo reference simulations were performed using TOPAS. Acquisitions of the Cherenkov signal were achieved using a cooled CCD camera and a timegated intensified CMOS camera. By fitting a modified Malus Law to the Cherenkov acquisitions, the total Cherenkov signal intensity and its purely polarized component was extracted. Signal source-to-camera distance of 0.5, 1, 2, 3 and 4 m were tested to evaluate this distance’s impact on the signal distributions. Projected percent depth dose (PPDD) and projected transverse profiles calculated from the different signal sources were then compared. Main results: All PPDDs at camera distances of 3 and 4 m agree with Monte Carlo (≤5%) over depths ranging from 1.5 to 16 cm. Cherenkov PPDDs at camera distances of 0.5 and 1 m show significant discrepancies (≥5%) compared to MC because no angular corrections are applied. Over the plateau region of projected transverse profiles, general agreement with MC is achieved. Thirteen of the 17 luminescence-based beam widths show ≤5% differences with MC. Significance: This study confirms the above-mentioned hypothesis up until the image quality diminishes. For this work’s setup, the optimal camera distance for dosimetry using Cherenkov polarized imaging was found to be between 3 and 4 m.
- 14 January 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (3)
Polarized Cherenkov light imaging dosimetry: the impact of source to detector distance
Objective: With every treatment vault being different, the impact of geometrical parameters such as the signal source-to-camera distance on dose proportionality must be evaluated. The aim of this study is to characterize the Cherenkov signal and polarization state as a function of the source-to-camera distance. Our hypothesis is that with increasing distance, the need for angular correction distributions decreases, resulting in acquisition of a polarized Cherenkov signal directly proportional to dose. Approach: A water tank and a polyvinyltoluene-based plastic scintillator volume were irradiated by a 6 MV beam to respectively produce Cherenkov emissions as well as a control signal. Monte Carlo reference simulations were performed using TOPAS. Acquisitions of the Cherenkov signal were achieved using a cooled CCD camera and a timegated intensified CMOS camera. By fitting a modified Malus Law to the Cherenkov acquisitions, the total Cherenkov signal intensity and its purely polarized component was extracted. Signal source-to-camera distance of 0.5, 1, 2, 3 and 4 m were tested to evaluate this distance’s impact on the signal distributions. Projected percent depth dose (PPDD) and projected transverse profiles calculated from the different signal sources were then compared. Main results: All PPDDs at camera distances of 3 and 4 m agree with Monte Carlo (≤5%) over depths ranging from 1.5 to 16 cm. Cherenkov PPDDs at camera distances of 0.5 and 1 m show significant discrepancies (≥5%) compared to MC because no angular corrections are applied. Over the plateau region of projected transverse profiles, general agreement with MC is achieved. Thirteen of the 17 luminescence-based beam widths show ≤5% differences with MC. Significance: This study confirms the above-mentioned hypothesis up until the image quality diminishes. For this work’s setup, the optimal camera distance for dosimetry using Cherenkov polarized imaging was found to be between 3 and 4 m.
- 21 July 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (15) , 15NT01
Development and characterization of the Hydra: a novel multi-headed, single optical channel scintillation detector
Objective. Plastic scintillation detectors (PSDs) possess many properties (small size, water-equivalence, real-time reading) that make them well suited for dosimetric applications in radiotherapy. Multi-point PSDs (mPSDs) further enhance capabilities of PSDs, incorporating multiple detection points cascaded within a single collecting optical fiber in order to provide more spatial information about the radiation field. The goal of this study was to develop and characterize a novel mPSD design, called Hydra, that possesses multiple optical fiber heads connected to a single optical fiber. Each head tip includes a single scintillating element, allowing to measure the dose simultaneously at three independent locations in space. Approach. The Hydra design consists of three Medscint proprietary scintillators with emission peaks at 434, 428 and 530 nm. The optical fibers of each head and the collecting fiber are made of PMMA (ESKA GH-4001, Mitsubitshi Chemical Co., Tokyo, Japan). The Hydra was used to measure output factors, dose profiles and percent-depth-dose (PDD) curves in water under a 6 MV photon beam, individually for each head as well as with all three heads in the irradiation beam. Main results. The deviation on output factors, when all three heads are in the irradiation field, remains within ±1.1% as compared to when only 1 head is in the irradiation field. For the profile and PDD curves, the deviation with the reference curves remains within ±2% in the high-dose and low-gradient regions. Significance. The Hydra offers a good control on the uniformity of light intensity coming from each scintillator, a freedom to measure independently in a non-contiguous space, and an easier and more accurate calibration procedure compared to previous mPSD designs. These advantages open the door to new possibilities for multi-point dosimetry applications.
- 21 July 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (15) , 15NT01
Development and characterization of the Hydra: a novel multi-headed, single optical channel scintillation detector
Objective. Plastic scintillation detectors (PSDs) possess many properties (small size, water-equivalence, real-time reading) that make them well suited for dosimetric applications in radiotherapy. Multi-point PSDs (mPSDs) further enhance capabilities of PSDs, incorporating multiple detection points cascaded within a single collecting optical fiber in order to provide more spatial information about the radiation field. The goal of this study was to develop and characterize a novel mPSD design, called Hydra, that possesses multiple optical fiber heads connected to a single optical fiber. Each head tip includes a single scintillating element, allowing to measure the dose simultaneously at three independent locations in space. Approach. The Hydra design consists of three Medscint proprietary scintillators with emission peaks at 434, 428 and 530 nm. The optical fibers of each head and the collecting fiber are made of PMMA (ESKA GH-4001, Mitsubitshi Chemical Co., Tokyo, Japan). The Hydra was used to measure output factors, dose profiles and percent-depth-dose (PDD) curves in water under a 6 MV photon beam, individually for each head as well as with all three heads in the irradiation beam. Main results. The deviation on output factors, when all three heads are in the irradiation field, remains within ±1.1% as compared to when only 1 head is in the irradiation field. For the profile and PDD curves, the deviation with the reference curves remains within ±2% in the high-dose and low-gradient regions. Significance. The Hydra offers a good control on the uniformity of light intensity coming from each scintillator, a freedom to measure independently in a non-contiguous space, and an easier and more accurate calibration procedure compared to previous mPSD designs. These advantages open the door to new possibilities for multi-point dosimetry applications.
- Open Access
- 7 May 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (10) , 105005
A systematic characterization of plastic scintillation dosimeters response in magnetic fields: I. Experimental measurements
Objective. This study aims to evaluate the performance of five distinct plastic scintillation dosimeters (PSDs) in magnetic fields, as well as to validate the accuracy of the hyperspectral approach for stem-effect correction. The effect of the magnetic field on different base core materials and components within the PSDs was also investigated, as well as the effect of field size and orientation. Approach. Each PSD was placed at 5 cm depth in a water tank inside an electromagnet gap. Magnetic fields, between 0 and 1.5 T, were set to be perpendicular to the 6 MeV photon beam and to the PSD axis. The detector axis was either parallel or perpendicular to the photon beam. Different field sizes were used. The hyperspectral technique was validated and used to determine the scintillation, fluorescence and Cherenkov components at different magnetic fields. Main results. The hyperspectral method accurately removes stem effects in magnetic fields, even when calibration is performed at 0 T. The stem light yield shows good agreement with clear fiber measurements, with relative differences within 2.0%. In the parallel orientation, the corrected PSD response is highly symmetric relative to magnetic field polarity, with a maximum variation of only 0.2% from unity. Scintillation light yield increases with magnetic field by 3.6%–6.25% depending on PSD properties. Cherenkov light yield varies up to 230% and down to 0.30% of the 0 T value, depending on magnetic field polarity. The impact of magnetic fields depends primarily on the properties of the scintillator itself, with polyvinyltoluene-based probes showing greater sensitivity than polystyrene-based probes. The inclusion of a wavelength shifter has minimal on the magnetic field’s effect on scintillation light yield. Normalized scintillation light yield decreases with smaller field sizes. Significance. PSDs are well-suited for accurate dosimetry in magnetic fields, provided that accurate stem-effect correction techniques are applied. The scintillator properties play a significant role in determining the PSD’s sensitivity to magnetic fields. The hyperspectral method is a robust approach for accurate stem-effect removal in such conditions.
- 7 May 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (10) , 105005
Open AccessA systematic characterization of plastic scintillation dosimeters response in magnetic fields: I. Experimental measurements
Objective. This study aims to evaluate the performance of five distinct plastic scintillation dosimeters (PSDs) in magnetic fields, as well as to validate the accuracy of the hyperspectral approach for stem-effect correction. The effect of the magnetic field on different base core materials and components within the PSDs was also investigated, as well as the effect of field size and orientation. Approach. Each PSD was placed at 5 cm depth in a water tank inside an electromagnet gap. Magnetic fields, between 0 and 1.5 T, were set to be perpendicular to the 6 MeV photon beam and to the PSD axis. The detector axis was either parallel or perpendicular to the photon beam. Different field sizes were used. The hyperspectral technique was validated and used to determine the scintillation, fluorescence and Cherenkov components at different magnetic fields. Main results. The hyperspectral method accurately removes stem effects in magnetic fields, even when calibration is performed at 0 T. The stem light yield shows good agreement with clear fiber measurements, with relative differences within 2.0%. In the parallel orientation, the corrected PSD response is highly symmetric relative to magnetic field polarity, with a maximum variation of only 0.2% from unity. Scintillation light yield increases with magnetic field by 3.6%–6.25% depending on PSD properties. Cherenkov light yield varies up to 230% and down to 0.30% of the 0 T value, depending on magnetic field polarity. The impact of magnetic fields depends primarily on the properties of the scintillator itself, with polyvinyltoluene-based probes showing greater sensitivity than polystyrene-based probes. The inclusion of a wavelength shifter has minimal on the magnetic field’s effect on scintillation light yield. Normalized scintillation light yield decreases with smaller field sizes. Significance. PSDs are well-suited for accurate dosimetry in magnetic fields, provided that accurate stem-effect correction techniques are applied. The scintillator properties play a significant role in determining the PSD’s sensitivity to magnetic fields. The hyperspectral method is a robust approach for accurate stem-effect removal in such conditions.
- Open Access
- 7 May 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (10) , 105004
A systematic characterization of plastic scintillation dosimeters response in magnetic fields: II. Monte Carlo simulations
Purpose. This study aims to investigate and validate the response of plastic scintillation dosimeters (PSDs) in the presence of magnetic fields using Monte Carlo simulations, focusing on the accuracy of electron fluence, dose calculations, and the optical processes of scintillation and Cherenkov radiation. Methods. Monte Carlo simulations, using EGSnrc and TOPAS, of the PSD response under magnetic fields were performed. First, electron fluence simulations were conducted with three different physics lists g4em-penelope, g4em-standard_opt3 and g4em-standard_opt4, with the goal of benchmarking their performance in magnetic fields. Secondly, a Fano test for dose calculations was performed using only the g4em-penelope physics list. Thirdly, the Cherenkov process under magnetic fields was validated against theoretical predictions. Finally, a PSD probe was modeled and simulated, with results compared against measurements. Results. The g4em-penelope physics list demonstrated a most balanced performance, showing the closest agreement with EGSnrc simulations and lower variability in magnetic fields than g4em-standard_opt4. Fano test results showed an accuracy of at least 0.36% for dose calculations. Simulations of Cherenkov radiation in ideal conditions were in agreement with theoretical predictions at both 0 T and 1.5 T. Monte Carlo simulations successfully reproduced experimental trends for Cherenkov radiation under magnetic fields. However, discrepancies were found, with deviations of up to 7.7% when electrons were deflected towards the tip and up to 21.0% in the opposite direction, likely due to modeling limitations. A key result is that Monte Carlo simulations of the scintillation process in magnetic fields failed to reproduce experimental observations. While experimental results showed a significant effect of magnetic fields on scintillation yield, the simulations did not reflect this behavior. Conclusion. This study establishes that TOPAS, specifically using the g4em-penelope physics list, is a reliable tool for simulating dose, electron fluence, and Cherenkov radiation in the presence of magnetic fields. However, significant discrepancies were observed in the scintillation processes, where Monte Carlo simulations failed to reproduce the effect of magnetic fields seen in experimental measurements. These findings point out the need for further refinement of simulation models, particularly in accurately representing scintillation under magnetic fields.
- 7 May 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (10) , 105004
Open AccessA systematic characterization of plastic scintillation dosimeters response in magnetic fields: II. Monte Carlo simulations
Purpose. This study aims to investigate and validate the response of plastic scintillation dosimeters (PSDs) in the presence of magnetic fields using Monte Carlo simulations, focusing on the accuracy of electron fluence, dose calculations, and the optical processes of scintillation and Cherenkov radiation. Methods. Monte Carlo simulations, using EGSnrc and TOPAS, of the PSD response under magnetic fields were performed. First, electron fluence simulations were conducted with three different physics lists g4em-penelope, g4em-standard_opt3 and g4em-standard_opt4, with the goal of benchmarking their performance in magnetic fields. Secondly, a Fano test for dose calculations was performed using only the g4em-penelope physics list. Thirdly, the Cherenkov process under magnetic fields was validated against theoretical predictions. Finally, a PSD probe was modeled and simulated, with results compared against measurements. Results. The g4em-penelope physics list demonstrated a most balanced performance, showing the closest agreement with EGSnrc simulations and lower variability in magnetic fields than g4em-standard_opt4. Fano test results showed an accuracy of at least 0.36% for dose calculations. Simulations of Cherenkov radiation in ideal conditions were in agreement with theoretical predictions at both 0 T and 1.5 T. Monte Carlo simulations successfully reproduced experimental trends for Cherenkov radiation under magnetic fields. However, discrepancies were found, with deviations of up to 7.7% when electrons were deflected towards the tip and up to 21.0% in the opposite direction, likely due to modeling limitations. A key result is that Monte Carlo simulations of the scintillation process in magnetic fields failed to reproduce experimental observations. While experimental results showed a significant effect of magnetic fields on scintillation yield, the simulations did not reflect this behavior. Conclusion. This study establishes that TOPAS, specifically using the g4em-penelope physics list, is a reliable tool for simulating dose, electron fluence, and Cherenkov radiation in the presence of magnetic fields. However, significant discrepancies were observed in the scintillation processes, where Monte Carlo simulations failed to reproduce the effect of magnetic fields seen in experimental measurements. These findings point out the need for further refinement of simulation models, particularly in accurately representing scintillation under magnetic fields.